Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Medicare

July 23, 2019 | Daily News

The Senate Finance Committee unveiled a long-awaited drug-pricing bill, to be marked up Thursday (July 25), that includes monumental changes to drug-pricing policy in Medicare and Medicaid -- including restructuring the Part D benefit, imposing controversial inflationary rebates in Medicare Parts B and D, and raising the rebate cap in Medicaid.

July 23, 2019 | Daily News

Lawmakers on the Senate Finance Committee did not hesitate to criticize the grand drug-pricing bargain Senate Finance Chair Chuck Grassley (R-IA) and ranking Democrat Ron Wyden (OR) rolled out Tuesday (July 23).

July 22, 2019 |

House Speaker Nancy Pelosi’s drug-price negotiation bill will be unveiled in early September to give drug makers less time to undermine the plan over the August recess and the Congressional Budget Office more time to formally score the bill, senior Pelosi aide Wendell Primus said Monday (July 22).

July 22, 2019 | Daily News

CMS Administrator Seema Verma took aim at public option proposals, which have become increasingly popular among the 2020 Democratic field and likened the policy to Medicare for All during a speech to Medicare stakeholders.

July 22, 2019 | Daily News

Justice in Aging says that so-called Duals Special Needs Plans look-alikes will interfere with CMS’ policy initiatives to improve care for those eligible for Medicare and Medicaid if the look-alike plans are left unchecked, and the group is urging CMS to force plans with majority duals enrollment to meet D-SNP requirements -- but the group says plans, not beneficiaries, should be the target of regulatory changes.

July 19, 2019 | Daily News

Executives from Pfizer, Genentech, Amgen and Alkermes met with White House officials Thursday (July 18) to discuss policies to control drug prices, according to sources familiar with the meeting.

July 19, 2019 | Daily News

Trial lawyers and beneficiary advocates say CMS’ decision to scrap its ban on nursing homes using pre-dispute, binding arbitration will deny beneficiaries access to the courts when a problem arises, even though the agency says nursing homes can’t force beneficiaries to agree to pre-dispute arbitration as a condition of receiving care.

July 19, 2019 | Daily News

The White House asked Democrats late Thursday (July 19) to include in a budget deal Senate Democratic drug-pricing policies that would save the government $115 billion, multiple sources say

July 17, 2019 | Daily News

CMS Administrator Seema Verma on Wednesday (July 17) touted the revamped accountable care organization program, which kicked in July 1, for leading more ACOs to take on risk, but the National Association of ACOs is worried that fewer new ACOs appear to be joining the program.

July 17, 2019 | Daily News

The House Energy & Commerce Committee on Wednesday (July 17) unanimously approved legislation that would delay Disproportionate Share Hospital (DSH) cuts, reauthorize Medicaid funding to the territories with increased oversight of Puerto Rico’s funding, fund community health centers and other extenders for four years, and tackle surprise billing.

July 17, 2019 | Daily News

National Kidney Foundation leaders expressed hope signals from the White House that FDA, CMS and the Center for Medicare & Medicaid Innovation (CMMI) are interested in advancing renal replacement therapies or devices could encourage more investment in medical product development for kidney disease.

July 16, 2019 | Daily News

CMS on Tuesday (July 16) repealed a prohibition on nursing homes using pre-dispute, binding arbitration agreements with residents, but the final rule also says nursing homes can’t require residents to sign binding arbitration agreements as a condition of admission or to continue receiving care at a facility.

July 16, 2019 | Daily News

CMS on Tuesday (July 16) proposed to loosen regulatory requirements for nursing homes by rolling back numerous safety and compliance provisions of an Obama-era rule that the agency now says is overly burdensome.

July 16, 2019 | Daily News

The Congressional Budget Office on Tuesday (July 16) reported that the wide-ranging Senate health committee bill, which aims to end surprise medical billing, increase transparency and lower prescription drug and other health costs, would save about $7.6 billion over 10 years, largely due to expected decreases in federal spending on insurance premiums as a result of the surprise billing provisions.

July 16, 2019 | Daily News

The House Ways & Means Committee on Tuesday (July 16) put together a rural and underserved communities health task force charged with finding bipartisan solutions to improve health care in those communities.

July 16, 2019 | Daily News

Senate health committee Chair Lamar Alexander (R-TN) called on CMS to quickly finalize a proposed fiscal 2020 hospital inpatient rule that would raise pay for low-wage hospitals by cutting pay for high-wage hospitals, saying this will help rural hospitals keep up with the cost of providing care, but hospital groups say keeping the proposal budget neutral is unnecessary and could be detrimental to some hospitals.

July 16, 2019 | Daily News

Sen. Kamala Harris is the latest Democratic presidential candidate to vow that Americans would not pay more for drugs than other countries pay, if she is elected.

July 16, 2019 | Daily News

Nearly all the Democratic members of the Senate Finance Committee asked ranking Democrat Sen. Ron Wyden (OR) to push for government price negotiation authority to be included in the committee’s drug-pricing package.

July 15, 2019 | Daily News

Democratic presidential candidate Sen. Amy Klobuchar (D-MN) released a plan for seniors on Friday (July 12) that includes a number of Medicare proposals, including expanding Medicare services for Alzheimer’s patients, supporting site-neutral payments and expanding telehealth, as other presidential hopefuls begin to release their own health plans.

July 15, 2019 | Daily News

CMS on Monday (July 15) proposed to cover acupuncture for Medicare beneficiaries with chronic low back pain who are enrolled in CMS-approved studies or clinic trials sponsored by the National Institutes of Health.

Pages